Heart Test Laboratories, Inc. (HSCS)

Heart Test Laboratories Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Year Ending	TTM	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Cash & Equivalents	7.08	1.66	0.92	0.72	0.5
Cash & Cash Equivalents	7.08	1.66	0.92	0.72	0.5
Cash Growth	266.48%	80.83%	26.92%	45.61%	-
Receivables	0.01	0	0	0	0
Inventory	0.67	0.68	0.67	0.75	0.86
Other Current Assets	0.93	0.36	0.34	0.16	0.18
Total Current Assets	8.69	2.7	1.93	1.64	1.54
Property, Plant & Equipment	0.54	0.59	0.16	0.29	0.42
Goodwill and Intangibles	1.57	0	0	0	0
Total Long-Term Assets	2.11	0.59	0.16	0.29	0.42
Total Assets	10.8	3.29	2.09	1.93	1.96
Accounts Payable	0.42	0.63	0.69	0.34	0.36
Current Debt	0.6	0.53	1.72	0.49	0.44
Other Current Liabilities	0.69	0.67	1.05	0.29	0.34
Total Current Liabilities	1.71	1.83	3.47	1.11	1.14
Long-Term Debt	0.46	1.04	4.44	2.59	0.5
Other Long-Term Liabilities	0	0.19	0.23	0.13	0
Total Long-Term Liabilities	0.46	1.22	4.67	2.72	0.5
Total Liabilities	2.17	3.06	8.15	3.84	1.64
Total Debt	1.06	1.57	6.16	3.08	0.94
Debt Growth	-36.92%	-74.59%	100.17%	226.59%	-
Retained Earnings	-65.52	-60.76	-54.4	-49.57	-47.12
Shareholders' Equity	8.63	0.23	-6.06	-1.91	0.32
Net Cash / Debt	6.02	0.09	-5.24	-2.36	-0.45
Net Cash / Debt Growth	2290.43%	-	-	-	-
Net Cash Per Share	11.19	1.19	-158.02	-71.08	-13.45
Working Capital	6.98	0.86	-1.54	0.52	0.4
Book Value Per Share	16.05	2.90	-182.46	-57.63	9.52

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).